We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advocacy Group Pushes FDA to Disqualify Minneapolis IRB, Investigators from Running Trials
Advocacy Group Pushes FDA to Disqualify Minneapolis IRB, Investigators from Running Trials
Public Citizen has called on the FDA to take strong action against two Minneapolis, Minn., investigators and the institutional review board (IRB) at Hennepin County Medical Center (HCMC) over investigational new drug (IND) and informed consent issues on some of their trials.